The effect of Irbesartan for cardiac function in patients with atrial fibrillation

The effect of Irbesartan for cardiac function in patients with atrial fibrillation - Irbesartan af study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004607

Enrollment

Registered

2010-11-23

Start date

2010-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with hypertension and atrial fibrillation

Interventions

The 100mg of Irbesartan will be administered to the hypertensive patients with atrial fibrillation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Hypertensive patients of outpatient clinic 2. Patients with atrial fibrillation 3. Patients who is not taking ARB 4. Patients who receive approval about this study after taking enough explanation

Exclusion criteria

Exclusion criteria: 1. Patients with renal failure 2. Patients who have severe infection and malignancy 3. Immunocompromised patients 4. Patients who are pregnant or hope for pregnancy 5. Patients who are judged inappropriate for the study by the attending physician

Design outcomes

Primary

Measure	Time frame
Influence on blood pressure and cardiac function	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026